Corcept Therapeutics Incorporated
Profit Margins
| Fiscal Year | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| FY2012 | 97.2% | -1,096.8% | -1,150.5% |
| FY2013 | 98.6% | -400.7% | -444.3% |
| FY2014 | 96.7% | -104.0% | -118.2% |
| FY2015 | 97.3% | -6.8% | -12.7% |
| FY2016 | 97.5% | 12.5% | 10.0% |
| FY2017 | 97.8% | 33.2% | 81.1% |
| FY2018 | 97.9% | 35.6% | 30.0% |
| FY2019 | 98.2% | 36.4% | 30.7% |
| FY2020 | 98.4% | 36.2% | 30.0% |
| FY2021 | 98.6% | 34.0% | 30.7% |
| FY2022 | 98.7% | 28.0% | 25.2% |
| FY2023 | 98.7% | 22.2% | 22.0% |
| FY2024 | 98.4% | 20.3% | 20.9% |
| FY2025 | 98.3% | 5.9% | 13.1% |